Ponatinib-induced pneumonitis with severe acute respiratory distress syndrome
Ponatinib is a third-generation tyrosine kinase inhibitor (TKI) that can effectively treat patients with acute lymphoblastic leukaemia (ALL), particularly those with Philadelphia chromosome-positive (Ph+ALL) subtype, who are resistant or have previously received other TKIs. We report a case of a 42-...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2023-11-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/4162 |